BioCentury
ARTICLE | Company News

Lexicon Genetics Inc., Bristol-Myers deal

October 23, 2000 7:00 AM UTC

LEXG granted BMY a non-exclusive sublicense to use certain aspects of LEXG's positive-negative selection and isogenic DNA technologies. BMY will use the technology to generate knockout mice for intern...